Price-target dispersion has started widening again across several corners of the market, creating a growing gap between where analysts see value and where stocks are currently trading. While not every disconnect deserves attention, large spreads can serve as a useful starting point for identifying names where sentiment, positioning, or recent market narratives may have moved faster than underlying expectations.
This week's screen uses FMP's Price Target Summary Bulk API to identify five companies trading materially below analyst consensus targets. Beyond highlighting the names themselves, the exercise offers a practical framework for systematically tracking valuation gaps across a broad coverage universe. Later in this article, we'll break down how the Price Target Summary Bulk API works, how the data is pulled, and how the screen can be replicated as part of a repeatable research workflow.
Key Takeaways
- This week's screen identified five companies - Boston Scientific, Universal Health Services, Intercontinental Exchange, Nasdaq, and S&P Global - where analyst consensus targets remain materially above current market prices.
- The largest disconnects are not concentrated in speculative or highly cyclical businesses. Instead, they appear in companies with recurring revenue streams, significant market positions, and broad analyst coverage.
- Price-target spreads become more informative when combined with operating data such as revenue growth, cash-flow generation, analyst revisions, and ownership trends, helping distinguish valuation gaps from fundamental disagreements.
This Week's Largest Price-Target Disconnects
Boston Scientific Corporation (BSX)
Current Price: $45.29 • Consensus Target: $82.9 • Upside Potential: 83.0%
Boston Scientific screens as the largest gap in this week's group, with analyst consensus sitting roughly 83% above the current market price. That spread arrives during a period when the company has remained operationally active but sentiment around several key product lines has weakened. In recent weeks, management acknowledged softer demand trends for its Watchman device franchise, a development that contributed to renewed scrutiny of growth assumptions across the cardiovascular portfolio.
What makes the signal interesting is the contrast between sentiment and fundamentals. Despite concerns around Watchman utilization, Boston Scientific continues to operate from a position of scale within cardiovascular devices, while recent acquisitions and strategic investments suggest management remains focused on expanding its addressable market. The gap between price and consensus appears less connected to a single earnings event and more reflective of uncertainty around the durability of future growth drivers.
For investors studying the disconnect, revenue segmentation data and income-statement trends provide useful context. Monitoring how cardiovascular growth offsets pressure in specific product categories may offer a clearer picture of whether the divergence reflects temporary skepticism or a broader reassessment of long-term expectations.
Universal Health Services, Inc. (UHS)
Current Price: $141.17 • Consensus Target: $216 • Upside Potential: 53.0%
Universal Health Services enters the screen with a 53% spread between its current market value and analyst consensus. Unlike many healthcare names where valuation debates revolve around innovation cycles or regulatory approvals, UHS is primarily tied to hospital utilization, patient volumes, reimbursement dynamics, and operating efficiency across its acute-care and behavioral-health networks.
The backdrop remains mixed. Earlier this year, the company reported quarterly results that narrowly missed profit expectations despite continued revenue growth, as patient admissions and utilization trends remained uneven across parts of the system. At the same time, management maintained revenue and earnings guidance that suggested underlying demand remains relatively stable.
The signal here is less about a single catalyst and more about the market's willingness to discount future healthcare utilization. When a hospital operator trades substantially below consensus estimates, the question often shifts toward whether investors are placing greater weight on reimbursement uncertainty, labor costs, or policy-related risks than analysts currently are. Admission metrics, same-facility performance data, and margin trends from future earnings reports are likely to remain the most informative datasets for evaluating that gap.
Intercontinental Exchange, Inc. (ICE)
Current Price: $133.88 • Consensus Target: $194 • Upside Potential: 44.9%
Intercontinental Exchange stands out as the only exchange operator in this week's list. With consensus targets nearly 45% above the current share price, analysts appear to be assigning greater value to the company's infrastructure position than the market currently reflects. ICE occupies a unique role across trading venues, clearing operations, fixed-income data services, and mortgage technology, making it less dependent on any single business line.
Exchange businesses often produce valuation disconnects during periods when trading activity, issuance trends, or capital-market sentiment become inconsistent. The market tends to focus on near-term transaction volumes, while analyst models frequently place greater emphasis on recurring revenue streams, data subscriptions, and long-duration infrastructure assets. That difference in perspective can create meaningful spreads between price and target estimates.
For readers examining the signal, the most relevant data points are likely to come from segment-level revenue disclosures, transaction statistics, and operating-margin trends. Looking beyond headline earnings and into how revenue is distributed across exchanges, data services, and mortgage technology can provide a more complete explanation for why consensus remains materially above current pricing.
Nasdaq, Inc. (NDAQ)
Current Price: $82.24 • Consensus Target: $113.83 • Upside Potential: 38.4%
Nasdaq appears alongside ICE as another market-infrastructure business whose valuation increasingly depends on data, software, and recurring services rather than pure trading activity. With analyst consensus sitting roughly 38% above the current share price, the spread suggests a meaningful difference between how the market is valuing those recurring businesses and how analysts are modeling them.
Over the past several years, Nasdaq has steadily diversified beyond its flagship exchange operations. Market participants often continue to associate the company with equity trading volumes, but a growing share of revenue comes from index licensing, analytics, anti-financial-crime software, governance solutions, and other technology-driven businesses. As a result, short-term market volatility does not always translate directly into the company's broader earnings profile.
The key question behind the signal is whether investors are currently emphasizing cyclical capital-markets activity more heavily than recurring revenue generation. Segment reporting, cash-flow trends, and revenue contributions from financial technology and market-services divisions provide a useful framework for assessing that distinction. Those datasets often reveal changes that are less visible from headline earnings figures alone.
S&P Global Inc. (SPGI)
Current Price: $410.92 • Consensus Target: $548.11 • Upside Potential: 33.4%
S&P Global completes this week's list with a price-to-target spread of approximately 33%. Although the percentage gap is smaller than the others in the screen, it remains notable given the company's position as one of the most established providers of financial data, credit ratings, benchmarks, and analytics.
The business occupies an unusual position within financial markets. Activity levels in debt issuance, credit markets, commodities, and institutional research all influence performance across different segments. That diversity can sometimes produce periods where investors focus on slowing activity in one area while analysts continue to assign value to the broader ecosystem of recurring information services and benchmark products.
From a signal perspective, S&P Global highlights how analyst targets often incorporate the durability of data franchises rather than just near-term market conditions. Revenue mix, ratings activity, subscription growth, and operating-margin trends are particularly useful datasets when evaluating whether consensus expectations remain aligned with underlying business performance. In situations like this, the size of the spread is often less important than understanding which business segments are driving the disagreement between market pricing and analyst assumptions.
The Bigger Story Behind the Spread
Viewed individually, each of this week's names has its own explanation. Boston Scientific is navigating product-specific questions inside a larger medical-device franchise. Universal Health Services sits at the intersection of healthcare utilization and reimbursement dynamics. ICE, Nasdaq, and S&P Global are all infrastructure businesses whose earnings profiles extend well beyond the market activities they are commonly associated with. Viewed together, however, a different pattern emerges.
None of these companies represent the type of deeply cyclical, highly speculative businesses that typically dominate screens built around large valuation gaps. Instead, the list is populated by established operators with recurring revenue streams, significant market positions, and broad analyst coverage. That distinction matters because it shifts the interpretation of the signal. The spread is not necessarily highlighting businesses where analysts and investors disagree on what the company is. Rather, it highlights situations where they appear to be assigning different weights to timing, growth durability, or near-term uncertainty.
That is where a price-target screen becomes more useful as a starting point than a conclusion.
The target gap itself tells us that a disagreement exists. Understanding the source of that disagreement requires layering in additional datasets. For example, comparing analyst targets against revenue and margin trends from FMP's Income Statement APIs can reveal whether consensus expectations are supported by recent operating performance or are based on longer-term assumptions that the market is discounting. Looking at Cash Flow Statement data can add another dimension, particularly for determining whether earnings expectations are translating into actual cash generation. Viewed through a broader dataset ecosystem such as FMP, the objective shifts from identifying valuation gaps to understanding the underlying drivers that may have created them. In many cases, that distinction becomes more informative than headline EPS estimates.
The same logic applies to sentiment. Analyst targets reflect one form of market opinion, but they are not the only one. Combining target data with analyst rating changes, insider trading activity, institutional ownership trends, or earnings-surprise history can help identify whether the spread is developing alongside improving conviction, deteriorating conviction, or simply a difference in time horizon between market participants and analysts. A large gap accompanied by stable estimates and consistent institutional ownership often tells a different story than a gap widening alongside estimate revisions and declining participation.
What stands out about this week's group is that the disconnects appear across multiple industries but revolve around a similar question: how much weight should be assigned to current conditions versus longer-term operating expectations? The healthcare names reflect that debate through utilization trends and product demand. The exchange and financial-data businesses reflect it through transaction activity, recurring revenue streams, and the durability of information-services franchises.
That is ultimately why price-target spreads remain a useful diagnostic rather than a valuation tool. They do not tell us where a stock should trade. They identify where expectations appear to be diverging. Once that divergence is identified, the more valuable exercise is tracing it back through earnings data, cash-flow generation, analyst revisions, ownership trends, and business fundamentals to understand what the market and consensus are seeing differently.
Creating a Structured Target-Gap Workflow
A price-target spread only becomes useful when the calculation can be reproduced reliably. That means fixing the data inputs, pulling them in a consistent sequence, and applying the same formula every time the screen runs. Once those elements are standardized, the exercise stops being a one-off comparison and turns into a process that can be refreshed on a schedule.
The only requirement before running the workflow is a valid API key.
Step 1: Pull Analyst Price Targets
The process starts by establishing where consensus currently sits. This is done by querying the Price Target Summary Bulk API, which returns average price targets along with analyst participation counts across the ticker set in a single call. That combination matters: the average target provides the reference level, while coverage depth helps contextualize how representative that number is. Together, they form the baseline against which market prices will be compared.
Endpoint:
|
https://financialmodelingprep.com/stable/price-target-summary-bulk?apikey=YOUR_API_KEY |
Sample Response:
|
[ { "symbol": "AAPL", "lastQuarterCount": "12", "lastQuarterAvgPriceTarget": "228.15", "lastYearAvgPriceTarget": "205.34" } ] |
Step 2: Pull Latest Market Prices
Once targets are in place, the next input is the current trading price. This comes from the Company Profile Data API, which includes the most recent quote used for comparison. At this stage, the goal isn't granularity or intraday precision — it's simply to anchor each name to the same market reference point so gaps are calculated consistently.
|
https://financialmodelingprep.com/stable/profile/AAPL?apikey=YOUR_API_KEY |
Step 3: Derive the Target Gap
Once both values are available, the gap itself is straightforward to compute. Express it as a percentage to normalize results across different price levels:
Upside % = (Price Target - Current Price) / Current Price × 100
Using percentages allows large-cap and lower-priced names to sit in the same ranking without distortion.
Step 4: Apply a Threshold Filter
The final layer is judgment. Most workflows introduce a minimum threshold — often around 20% — to filter out routine variance and focus attention on gaps that are large enough to matter. At this stage, analyst coverage becomes part of the interpretation: a wide gap backed by broad, recent coverage carries a different weight than one driven by a small or outdated estimate set.
Structured this way, the process moves beyond a simple valuation screen. It becomes a repeatable diagnostic tool — one that highlights where price and consensus are drifting apart and does so in a way that can be refreshed, audited, and scaled across time and coverage universes.
Standardizing a Signal Across Research Teams
Most quantitative workflows begin quietly — a model or screen built by a single analyst to answer a recurring question with greater consistency. The first version usually lives in a spreadsheet or a small script: efficient, practical, and tailored to the needs of one desk. The turning point arrives when the signal proves useful enough that colleagues begin asking for it. Replication follows, and with it comes an unintended side effect: slight variations in endpoints, refresh schedules, or calculation logic start producing subtly different results.
At that stage, the analyst who created the workflow often becomes an informal architect of standardization. The challenge shifts from running the screen to defining the method behind it. Institutional value emerges when the process is formalized: the data sources are fixed, the sequence of API pulls is documented, formulas are locked, and thresholds are explicitly defined. Once those elements are stabilized, the workflow stops being a personal tool and begins to function as a shared research input.
Moving the process into a centralized dashboard with scheduled updates is usually the next step in that evolution. Instead of circulating spreadsheets or ad-hoc scripts, teams interact with the same data pipeline and the same calculation framework. This reduces workflow fragmentation across research groups and allows portfolio managers, analysts, and risk teams to reference the same signal simultaneously. When everyone is drawing from the same dataset and methodology, discussions shift away from reconciling numbers and toward interpreting what the signal actually means.
Standardization also strengthens governance and transparency. A centralized workflow creates a visible audit trail: where the data originated, when it refreshed, and how each metric was derived. That lineage matters in institutional environments where reproducibility is essential. When colleagues run the same query and obtain the same result, the signal becomes dependable infrastructure rather than a one-off analytical shortcut.
Scaling that kind of workflow across a team requires stable access to the underlying datasets and consistent distribution across users. Infrastructure becomes less about adding features and more about removing friction from the research process. Platforms designed for institutional usage — such as FMP's Enterprise plan — provide the access controls, refresh stability, and shared environment needed when a desk-level workflow transitions into a broader research tool.
When that transition happens successfully, the model itself changes role. The target-gap screen is no longer simply a clever comparison between price and analyst targets. It becomes part of the firm's analytical framework — a standardized diagnostic that multiple teams can rely on to identify where market pricing and consensus expectations are beginning to drift apart.
When the Market Reprices Before the Story Catches Up
Large price-target gaps are rarely the story themselves. More often, they are evidence that different parts of the market are interpreting the same information through different time horizons. Using the Price Target Summary Bulk API as a starting point makes those disconnects easier to identify and easier to investigate before consensus and market pricing begin telling the same story.
If you enjoyed this analysis, you'll also want to read: Weekly Signals Desk | Five Notable Valuation Disconnects from the FMP API (June 8-12)
Disclosure: Signals Desk content is provided for informational and analytical purposes only and does not constitute investment advice or trade recommendations. The analysis reflects interpretation of market data and publicly disclosed or third-party information, including data accessed via Financial Modeling Prep APIs, at the time of publication. Signals discussed are probabilistic, can be wrong, and may change as market conditions and consensus data evolve. This content should be considered alongside broader research, individual objectives, and risk assessment.
